A.R.T. Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

A.R.T. Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,073	Closed	-$711K	–	1800
2018 Q4	$711K	Buy	+5,073	New	+$770K	0.05%	569
2018 Q3	–	Sell	-19,496	Closed	-$3.38M	–	1883
2018 Q2	$3.38M	Buy	+19,496	New	+$2.93M	0.14%	199
2017 Q3	–	Sell	-2,600	Closed	-$208K	–	1861
2017 Q2	$208K	Buy	+2,600	New	+$144K	0.01%	1146
2016 Q1	–	Sell	-14,794	Closed	-$420K	–	1807
2015 Q4	$420K	Sell	14,794 -10,790	-42%	-$290K	0.02%	935
2015 Q3	$447K	Buy	+25,584	New	+$501K	0.02%	918

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

A.R.T. Advisors's LOXO Position: Q1 2019 in Review

A.R.T. Advisors sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 5,073 shares — an estimated $711K sold.

A.R.T. Advisors first reported a position in LOXO in Q3 2015 and held it in 5 quarters. The position peaked at $3.38M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

A.R.T. Advisors reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
A.R.T. Advisors sold 5,073 Loxo Oncology, Inc shares in Q1 2019, an estimated $711K.
A.R.T. Advisors first reported a position in Loxo Oncology, Inc in Q3 2015 and held it in 5 quarters.
A.R.T. Advisors's Loxo Oncology, Inc position peaked at $3.38M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on A.R.T. Advisors's 13F filing for Q1 2019, filed 15 May 2019.